No.21
Disclosure
2026/11/10 18:23
取締役一覧と役割
List of Directors and Their Roles and Functions
List of Directors and Their Roles and Functions
00719 SHANDONG XINHUA PHARMACEUTICAL COMPANY LIMITEDSHANDONG XINHUAHong Kong Stock Exchange
21 posts
SHANDONG XINHUA PHARMACEUTICAL COMPANY LIMITED (00719) at a glance
Prices are from Yahoo! Finance and may be delayed. Always check the latest price before trading.
SHANDONG XINHUA PHARMACEUTICAL COMPANY LIMITED (00719) Stock Price History
SHANDONG XINHUA PHARMACEUTICAL COMPANY LIMITED closed at HK$5.42 on Nov 10, 2026, −4.7% over 1 month, −24.9% over 1 year.
Price5-day MA25-day MAHang Seng IndexDisclosures
1-Month HighHK$5.59Oct 12
1-Month LowHK$5.31Oct 22
1-Week Change−0.5%vs Nov 3
1-Month Change−4.7%vs Oct 9
If you had invested HK$10,000 1 month ago, it would be worth HK$9,696 today (−3.0%).Price change only; dividends and fees are not included.
Over the same period the Hang Seng Index moved +1.2%, while this stock moved −3.0%.
Last 10 Trading Days
| Date | Close | Change | % Change |
|---|---|---|---|
| Nov 10 (Tue) | HK$5.42 | +0.05 | +0.93% |
| Nov 9 (Mon) | HK$5.37 | −0.11 | −1.92% |
| Nov 6 (Fri) | HK$5.48 | −0.08 | −1.35% |
| Nov 5 (Thu) | HK$5.55 | +0.10 | +1.83% |
| Nov 4 (Wed) | HK$5.45 | +0.00 | +0.09% |
| Nov 3 (Tue) | HK$5.45 | +0.02 | +0.28% |
| Nov 2 (Mon) | HK$5.43 | +0.08 | +1.50% |
| Oct 30 (Fri) | HK$5.35 | −0.06 | −1.11% |
| Oct 29 (Thu) | HK$5.41 | −0.02 | −0.46% |
| Oct 28 (Wed) | HK$5.44 | +0.07 | +1.40% |
Price5-day MA25-day MAHang Seng IndexDisclosures
3-Month HighHK$6.31Sep 21
3-Month LowHK$5.31Oct 22
1-Month Change−4.7%vs Oct 9
3-Month Change−11.8%vs Aug 10
If you had invested HK$10,000 3 months ago, it would be worth HK$8,820 today (−11.8%).Price change only; dividends and fees are not included.
Over the same period the Hang Seng Index moved −5.3%, while this stock moved −11.8%.
Last 10 Trading Days
| Date | Close | Change | % Change |
|---|---|---|---|
| Nov 10 (Tue) | HK$5.42 | +0.05 | +0.93% |
| Nov 9 (Mon) | HK$5.37 | −0.11 | −1.92% |
| Nov 6 (Fri) | HK$5.48 | −0.08 | −1.35% |
| Nov 5 (Thu) | HK$5.55 | +0.10 | +1.83% |
| Nov 4 (Wed) | HK$5.45 | +0.00 | +0.09% |
| Nov 3 (Tue) | HK$5.45 | +0.02 | +0.28% |
| Nov 2 (Mon) | HK$5.43 | +0.08 | +1.50% |
| Oct 30 (Fri) | HK$5.35 | −0.06 | −1.11% |
| Oct 29 (Thu) | HK$5.41 | −0.02 | −0.46% |
| Oct 28 (Wed) | HK$5.44 | +0.07 | +1.40% |
Price25-day MA75-day MAHang Seng IndexDisclosures
6-Month HighHK$6.54May 11
6-Month LowHK$5.24Jun 26
3-Month Change−11.8%vs Aug 10
6-Month Change−12.7%vs May 8
If you had invested HK$10,000 6 months ago, it would be worth HK$8,287 today (−17.1%).Price change only; dividends and fees are not included.
Over the same period the Hang Seng Index moved −7.0%, while this stock moved −17.1%.
Monthly Closes
| Month | Month-End Close | Monthly % |
|---|---|---|
| Nov 2026 | HK$5.42 | +1.3% |
| Oct 2026 | HK$5.35 | −8.0% |
| Sep 2026 | HK$5.82 | +3.7% |
| Aug 2026 | HK$5.61 | −8.5% |
| Jul 2026 | HK$6.13 | +10.3% |
| Jun 2026 | HK$5.56 | −7.3% |
| May 2026 | HK$6.00 | −3.1% |
Price25-day MA75-day MAHang Seng IndexDisclosures
52-Week HighHK$7.30Nov 26
52-Week LowHK$5.24Jun 26
Year to Date−17.8%vs Dec 31
From 52-Week High−25.8%Nov 26
If you had invested HK$10,000 1 year ago, it would be worth HK$7,507 today (−24.9%).Price change only; dividends and fees are not included.
Over the same period the Hang Seng Index moved −8.0%, while this stock moved −24.9%.
Monthly Closes
| Month | Month-End Close | Monthly % |
|---|---|---|
| Nov 2026 | HK$5.42 | +1.3% |
| Oct 2026 | HK$5.35 | −8.0% |
| Sep 2026 | HK$5.82 | +3.7% |
| Aug 2026 | HK$5.61 | −8.5% |
| Jul 2026 | HK$6.13 | +10.3% |
| Jun 2026 | HK$5.56 | −7.3% |
| May 2026 | HK$6.00 | −3.1% |
| Apr 2026 | HK$6.19 | −2.8% |
| Mar 2026 | HK$6.37 | −7.9% |
| Feb 2026 | HK$6.92 | −1.4% |
| Jan 2026 | HK$7.02 | +6.5% |
| Dec 2025 | HK$6.59 | −7.6% |
| Nov 2025 | HK$7.13 | +2.6% |
Price13-week MA26-week MAHang Seng Index
3-Year HighHK$8.85Jul 14, 2025
3-Year LowHK$5.00Jan 29, 2024
Annualized Return−1.7%
Max Drawdown−40.8%
If you had invested HK$10,000 3 years ago, it would be worth HK$9,492 today (−5.1%).Price change only; dividends and fees are not included.
Over the same period the Hang Seng Index moved +40.7%, while this stock moved −5.1%.
Yearly Closes
| Year | Year-End Close | Yearly % |
|---|---|---|
| 2026 (YTD) | HK$5.42 | −17.8% |
| 2025 | HK$6.59 | ― |
Price13-week MA26-week MAHang Seng Index
5-Year HighHK$15.62Dec 12, 2022
5-Year LowHK$3.81Sep 19, 2022
Annualized Return+6.7%
Max Drawdown−68.0%
If you had invested HK$10,000 5 years ago, it would be worth HK$13,791 today (+37.9%).Price change only; dividends and fees are not included.
Over the same period the Hang Seng Index moved −2.0%, while this stock moved +37.9%.
Yearly Closes
| Year | Year-End Close | Yearly % |
|---|---|---|
| 2026 (YTD) | HK$5.42 | −17.8% |
| 2025 | HK$6.59 | ― |
Price1-year MA2-year MAHang Seng Index
All-Time HighHK$8.15Dec 2022
All-Time LowHK$0.46May 2000
Total Change+907.4%vs Feb 2000
Annualized Return+9.0%
If you had invested HK$10,000 in Feb 2000, it would be worth HK$100,743 today (+907.4%).Price change only; dividends and fees are not included.
Over the same period the Hang Seng Index moved +43.0%, while this stock moved +907.4%.
Yearly Closes
| Year | Year-End Close | Yearly % |
|---|---|---|
| 2026 (YTD) | HK$5.42 | −17.8% |
| 2025 | HK$6.59 | +13.0% |
| 2024 | HK$5.83 | +0.9% |
| 2023 | HK$5.78 | −29.1% |
| 2022 | HK$8.15 | +75.3% |
| 2021 | HK$4.65 | +31.0% |
| 2020 | HK$3.55 | −7.1% |
| 2019 | HK$3.82 | +4.9% |
| 2018 | HK$3.64 | −43.0% |
| 2017 | HK$6.39 | +58.4% |
| 2016 | HK$4.03 | +1.9% |
| 2015 | HK$3.95 | +38.5% |
| 2014 | HK$2.85 | +67.1% |
| 2013 | HK$1.71 | +1.8% |
| 2012 | HK$1.68 | +6.9% |
| 2011 | HK$1.57 | −38.2% |
| 2010 | HK$2.54 | +14.2% |
| 2009 | HK$2.22 | +143.0% |
| 2008 | HK$0.92 | −56.9% |
| 2007 | HK$2.12 | +93.0% |
| 2006 | HK$1.10 | +30.0% |
| 2005 | HK$0.85 | −21.4% |
| 2004 | HK$1.08 | −24.3% |
| 2003 | HK$1.42 | +13.5% |
| 2002 | HK$1.25 | −22.4% |
| 2001 | HK$1.62 | +153.1% |
| 2000 | HK$0.64 | ― |
Daily, weekly and monthly closes (Yahoo! Finance, split-adjusted, dividends excluded). "All" covers the range Yahoo provides (from Feb 2000). Please check the latest prices before trading.
Posts
This board is shared with the Japanese and Chinese versions. Feel free to write in English, Chinese or Japanese.
No.20
Disclosure
2026/11/10 18:22
海外規制公告（取締役会・監事会決議）
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Delete
No.19
Disclosure
2026/11/10 18:21
取締役・重要な執行役員の異動／取締役の選任（総会付議）／臨時株主総会の結果
Poll Results of The Extraordinary General Meeting and Change of the Chairman of Company
Poll Results of The Extraordinary General Meeting and Change of the Chairman of Company
Delete
No.18
Disclosure
2026/11/06 17:48
海外規制公告（その他）
Overseas Regulatory Announcement-Announcement on Ketorolac Tromethamine Injection Having Obtained Drug Registration Certificate
Overseas Regulatory Announcement-Announcement on Ketorolac Tromethamine Injection Having Obtained Drug Registration Certificate
Delete
No.17
Disclosure
2026/10/28 17:46
海外規制公告（事業の状況）
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Delete
No.16
Disclosure
2026/10/28 17:45
海外規制公告（取締役会・監事会決議）
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Delete
No.15
Disclosure
2026/10/28 17:44
四半期決算／内部情報（インサイド・インフォメーション）
Unaudited Quarterly Results Announcement For The Nine Months Ended 30 September 2026
Unaudited Quarterly Results Announcement For The Nine Months Ended 30 September 2026
Delete
No.14
Disclosure
2026/10/19 19:08
海外規制公告（その他）
Overseas Regulatory Announcement-Announcement on Nimodipine Tablets Having Passed the Generics Consistency Evaluation
Overseas Regulatory Announcement-Announcement on Nimodipine Tablets Having Passed the Generics Consistency Evaluation
Delete
No.13
Disclosure
2026/10/16 17:35
臨時株主総会の招集／取締役の選任（総会付議）／株主名簿の閉鎖
Notice of The Extraordinary General Meeting
Notice of The Extraordinary General Meeting
Delete
No.12
Disclosure
2026/10/14 17:31
取締役会の開催日
Announcement Notice of Board Meeting
Announcement Notice of Board Meeting
Delete
No.11
Disclosure
2026/10/13 18:15
海外規制公告（その他）
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Delete
No.10
Disclosure
2026/10/09 18:37
海外規制公告（取締役会・監事会決議）
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Delete
No.9
Disclosure
2026/10/09 18:36
取締役・重要な執行役員の異動
Proposed Appointment of Executive Director
Proposed Appointment of Executive Director
Delete
No.8
Disclosure
2026/10/08 17:50
海外規制公告（その他）
Overseas Regulatory Announcement-Announcement on Sacubitril Valsartan Sodium Tablets Having Obtained Drug Registration Certificate
Overseas Regulatory Announcement-Announcement on Sacubitril Valsartan Sodium Tablets Having Obtained Drug Registration Certificate
Delete
No.7
Disclosure
2026/09/29 17:52
海外規制公告
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Delete
No.6
Disclosure
2026/09/29 17:51
海外規制公告（その他）
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Delete
No.5
Disclosure
2026/09/22 18:27
海外規制公告（その他）
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Delete
No.4
Disclosure
2026/09/22 17:41
中間報告書
2026 Interim Report
2026 Interim Report
Delete
No.3
Disclosure
2026/09/18 17:59
海外規制公告（その他）
Overseas Regulatory Announcement-Announcement on Levocarnitine Oral Solution having obtained Drug Registration Certificate
Overseas Regulatory Announcement-Announcement on Levocarnitine Oral Solution having obtained Drug Registration Certificate
Delete
No.2
Disclosure
2026/09/18 17:59
海外規制公告（その他）
Overseas Regulatory Announcement-Announcement on Magnesium Sulfate, Sodium Sulfate and Potassium Sulfate Concentrate Oral Solution Having Obtained Drug Registration Certificate
Overseas Regulatory Announcement-Announcement on Magnesium Sulfate, Sodium Sulfate and Potassium Sulfate Concentrate Oral Solution Having Obtained Drug Registration Certificate
Delete
No.1
Disclosure
2026/09/18 17:58
海外規制公告（その他）
Overseas Regulatory Announcement-Announcement on Donepezil Hydrochloride Orally Disintegrating Tablets of Subsidiary Having Obtained Drug Registration Certificate
Overseas Regulatory Announcement-Announcement on Donepezil Hydrochloride Orally Disintegrating Tablets of Subsidiary Having Obtained Drug Registration Certificate
Delete
Write on the SHANDONG XINHUA PHARMACEUTICAL COMPANY LIMITED board
More Chinese stocks in English
- Auto Italia Holdings Limited00720
- UMP HEALTHCARE HOLDINGS LIMITED00722
- Reliance Global Holdings Limited00723
- Perennial International Limited00725
- DIT Group Limited00726
- Sinopros Corporation Limited00727
- China Telecom Corporation Limited00728
- Capital Industrial Financial Services Group Limited00730
- C&D Newin Paper & Pulp Corporation Limited00731
- Truly International Holdings Limited00732
- Hopefluent Group Holdings Limited00733
- China Properties Investment Holdings Limited00736